Grant: Discovery Grants Program - Individual
University of Saskatchewan
$28,000.00
ELR-CXC chemokine antagonism in neutrophilic inflammation
FY 2011-12
Summary
While we understand the basic biology of inflammation, we have yet to generate a reasoned overview of how the individual components interact with each other. Anecdotal evidence suggests that there exists a much greater interdependence of these functions than previously appreciated. We have developed a new tool with which we can investigate these processes, an
anti-inflammatory drug, called G31P, that it very specifically blocks an entire class of inflammatory molecules (chemokines). It is highly effective as an anti-inflammatory agent. In fact, it is much more effective than we would have predicted, so we wish to know exactly how it works in blocking the activities of other classes of inflammatory molecules, and how these different pathways intersect. We have some evidence that is also blocks processes not traditionally thought of as inflammatory (e.g., the spread of cancer cells in the body). We will use a combination of test tube and live animal studies to investigate the roles of these various systems (ie, the chemokine and non-chemokine pathways) in the body. Overall, these studies are designed allow us to gain a greater understanding of inflammatory processes such that we can better manage them clinically.
Program
Discovery Grants Program - Individual
Recipient
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
227099-2009
Name nom
Gordon, John
Department département
Medicine
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
28000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
3
Nb partie
5
Application title
ELR-CXC chemokine antagonism in neutrophilic inflammation
Keyword
NSERC
Application summary
While we understand the basic biology of inflammation, we have yet to generate a reasoned overview of how the individual components interact with each other. Anecdotal evidence suggests that there exists a much greater interdependence of these functions than previously appreciated. We have developed a new tool with which we can investigate these processes, an
anti-inflammatory drug, called G31P, that it very specifically blocks an entire class of inflammatory molecules (chemokines). It is highly effective as an anti-inflammatory agent. In fact, it is much more effective than we would have predicted, so we wish to know exactly how it works in blocking the activities of other classes of inflammatory molecules, and how these different pathways intersect. We have some evidence that is also blocks processes not traditionally thought of as inflammatory (e.g., the spread of cancer cells in the body). We will use a combination of test tube and live animal studies to investigate the roles of these various systems (ie, the chemokine and non-chemokine pathways) in the body. Overall, these studies are designed allow us to gain a greater understanding of inflammatory processes such that we can better manage them clinically.